PROFOUND MEDICAL CORP. (PROF) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
9/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LosePROF / S&P 2.62% / 15.20% |
WinPROF / S&P 79.94% / 15.00% |
LosePROF / S&P 15.00% / 50.40% |
| 2026-Q11/3 |
LosePROF / S&P -17.66% / -4.33% |
WinPROF / S&P 75.79% / 11.30% |
LosePROF / S&P -83.33% / 27.70% |
| 2025-Q42/3 |
WinPROF / S&P 60.94% / 2.65% |
WinPROF / S&P 65.28% / 9.00% |
LosePROF / S&P -66.67% / 13.40% |
| 2025-Q30/3 |
LosePROF / S&P -17.12% / 8.12% |
LosePROF / S&P PROF unavailable / 4.61% |
LosePROF / S&P PROF unavailable / 13.45% |
| 2025-Q20/3 |
LosePROF / S&P 1.37% / 10.94% |
LosePROF / S&P PROF unavailable / 4.83% |
LosePROF / S&P PROF unavailable / 10.63% |
| 2025-Q10/3 |
LosePROF / S&P -22.50% / -4.27% |
LosePROF / S&P PROF unavailable / 4.98% |
LosePROF / S&P PROF unavailable / 10.57% |
| 2024-Q40/3 |
LosePROF / S&P -5.65% / 2.41% |
LosePROF / S&P PROF unavailable / 5.25% |
LosePROF / S&P PROF unavailable / 6.15% |
| 2024-Q30/3 |
LosePROF / S&P -5.13% / 5.89% |
LosePROF / S&P PROF unavailable / 5.89% |
LosePROF / S&P PROF unavailable / 6.11% |
| 2024-Q20/3 |
LosePROF / S&P -1.64% / 4.28% |
LosePROF / S&P PROF unavailable / 5.38% |
LosePROF / S&P PROF unavailable / 5.12% |
| 2024-Q10/3 |
LosePROF / S&P 0.47% / 10.56% |
LosePROF / S&P PROF unavailable / 5.71% |
LosePROF / S&P PROF unavailable / 5.59% |
| 2023-Q40/3 |
LosePROF / S&P -16.76% / 11.69% |
LosePROF / S&P PROF unavailable / 6.81% |
LosePROF / S&P PROF unavailable / 7.78% |
| 2023-Q30/3 |
LosePROF / S&P -21.60% / -3.27% |
LosePROF / S&P PROF unavailable / 7.52% |
LosePROF / S&P PROF unavailable / -5.03% |
| 2023-Q21/3 |
WinPROF / S&P 40.04% / 8.74% |
LosePROF / S&P PROF unavailable / 9.50% |
LosePROF / S&P PROF unavailable / -8.57% |
| 2023-Q10/3 |
LosePROF / S&P -14.69% / 7.50% |
LosePROF / S&P PROF unavailable / 10.77% |
LosePROF / S&P PROF unavailable / -15.69% |
| 2022-Q41/3 |
WinPROF / S&P 169.55% / 7.56% |
LosePROF / S&P PROF unavailable / 11.88% |
LosePROF / S&P PROF unavailable / -17.99% |
| 2022-Q30/3 |
LosePROF / S&P -44.58% / -4.88% |
LosePROF / S&P PROF unavailable / 13.47% |
LosePROF / S&P PROF unavailable / -1.41% |
| 2022-Q20/3 |
LosePROF / S&P -19.00% / -16.10% |
LosePROF / S&P PROF unavailable / 13.71% |
LosePROF / S&P PROF unavailable / 11.04% |
| 2022-Q10/3 |
LosePROF / S&P -19.86% / -4.60% |
LosePROF / S&P PROF unavailable / 15.97% |
LosePROF / S&P PROF unavailable / 42.23% |
| 2021-Q40/3 |
LosePROF / S&P -23.29% / 11.03% |
LosePROF / S&P PROF unavailable / 15.00% |
LosePROF / S&P PROF unavailable / 96.40% |
| 2021-Q30/3 |
LosePROF / S&P -10.51% / 0.58% |
LosePROF / S&P PROF unavailable / 10.77% |
LosePROF / S&P PROF unavailable / 69.42% |
| 2021-Q20/3 |
LosePROF / S&P -18.77% / 8.55% |
LosePROF / S&P PROF unavailable / 6.58% |
LosePROF / S&P PROF unavailable / 51.81% |
| 2021-Q10/3 |
LosePROF / S&P -2.04% / 6.17% |
LosePROF / S&P PROF unavailable / -1.06% |
LosePROF / S&P PROF unavailable / 7.39% |
| 2020-Q41/3 |
WinPROF / S&P 16.55% / 12.15% |
LosePROF / S&P PROF unavailable / -3.72% |
LosePROF / S&P PROF unavailable / -33.42% |
| 2020-Q30/3 |
LosePROF / S&P 4.13% / 8.93% |
LosePROF / S&P PROF unavailable / -2.04% |
LosePROF / S&P PROF unavailable / -27.10% |
| 2020-Q21/3 |
WinPROF / S&P 73.92% / 20.54% |
LosePROF / S&P PROF unavailable / -0.46% |
LosePROF / S&P PROF unavailable / -27.11% |
| 2020-Q11/3 |
WinPROF / S&P -11.05% / -19.60% |
LosePROF / S&P PROF unavailable / 3.47% |
LosePROF / S&P PROF unavailable / -14.75% |
| 2019-Q40/3 |
LosePROF / S&P PROF unavailable / 9.07% |
LosePROF / S&P PROF unavailable / 5.36% |
LosePROF / S&P PROF unavailable / 2.99% |
| 2019-Q30/3 |
LosePROF / S&P PROF unavailable / 1.70% |
LosePROF / S&P PROF unavailable / 5.02% |
LosePROF / S&P PROF unavailable / 0.21% |
| 2019-Q20/3 |
LosePROF / S&P PROF unavailable / 4.30% |
LosePROF / S&P PROF unavailable / 6.64% |
LosePROF / S&P PROF unavailable / 8.65% |
| 2019-Q10/3 |
LosePROF / S&P PROF unavailable / 13.65% |
LosePROF / S&P PROF unavailable / 8.12% |
LosePROF / S&P PROF unavailable / 14.29% |
| 2018-Q40/3 |
LosePROF / S&P PROF unavailable / -13.52% |
LosePROF / S&P PROF unavailable / 9.05% |
LosePROF / S&P PROF unavailable / 18.23% |
| 2018-Q30/3 |
LosePROF / S&P PROF unavailable / 7.71% |
LosePROF / S&P PROF unavailable / 10.21% |
LosePROF / S&P PROF unavailable / 19.06% |
| 2018-Q20/3 |
LosePROF / S&P PROF unavailable / 3.43% |
LosePROF / S&P PROF unavailable / 9.03% |
LosePROF / S&P PROF unavailable / 14.46% |
| 2018-Q10/3 |
LosePROF / S&P PROF unavailable / -0.76% |
LosePROF / S&P PROF unavailable / 7.68% |
LosePROF / S&P PROF unavailable / 12.46% |
| 2017-Q40/3 |
LosePROF / S&P PROF unavailable / 6.64% |
LosePROF / S&P PROF unavailable / 7.03% |
LosePROF / S&P PROF unavailable / 13.82% |
| 2017-Q30/3 |
LosePROF / S&P PROF unavailable / 4.48% |
LosePROF / S&P PROF unavailable / 5.68% |
LosePROF / S&P PROF unavailable / 17.57% |
| 2017-Q20/3 |
LosePROF / S&P PROF unavailable / 3.09% |
LosePROF / S&P PROF unavailable / 4.83% |
LosePROF / S&P PROF unavailable / 17.74% |
| 2017-Q10/3 |
LosePROF / S&P PROF unavailable / 6.07% |
LosePROF / S&P PROF unavailable / 3.67% |
LosePROF / S&P PROF unavailable / 13.32% |
| 2016-Q40/3 |
LosePROF / S&P PROF unavailable / 3.82% |
LosePROF / S&P PROF unavailable / 2.09% |
LosePROF / S&P PROF unavailable / 7.05% |
| 2016-Q30/3 |
LosePROF / S&P PROF unavailable / 3.85% |
LosePROF / S&P PROF unavailable / 0.20% |
LosePROF / S&P PROF unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PROF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 55.70% | 20.78% |
| Annualized return | 55.70% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | PROF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -56.34% | 83.14% |
| Annualized return | -15.27% | 12.86% |
10Y · 2019-10-29 to 2026-08-27
| Metric | PROF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -28.30% | 319.30% |
| Annualized return | -3.27% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |